APPLICATION
ANDA203793
TYPE
ANDA
ORIGINAL APPROVAL
2015-11-03
LATEST ACTION
2023-03-08
ROUTE
RESPIRATORY (INHALATION), INHALATION
DOSAGE FORM
LIQUID
MARKETING STATUS
Prescription
Products
SEVOFLURANEPrescription
SEVOFLURANE 100% · LIQUID · INHALATION
Approval history
2023-03-08Labeling · Supplement 13 · standardAP
2023-03-08Labeling · Supplement 14 · standardAP
2023-03-08Labeling · Supplement 12 · standardAP
2020-08-11Labeling · Supplement 2 · standardAP
2015-11-03UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.